Scholarlink

<p><i>GLI1</i>-altered soft tissue tumor is a recently recognized entity featuring <i>GLI1</i> fusions or amplifications, with predilection for the head and neck region and potential for metastasis. We report an additional case arising in the tongue of a 9-year-old boy with growth hormone insufficiency and epilepsy. Imaging showed an enhancing midline dorsal tongue lesion. Incisional biopsy revealed a multilobulated submucosal proliferation of monomorphic epithelioid-to-ovoid cells with prominent perivascular distribution around branching vessels and focal protrusion into vascular spaces. Tumor cells were GLUT-1 positive and negative for S100, GFAP, pan-cytokeratin, SMA, WT-1, CD31, CD34, STAT6, β-catenin, and HMB-45, with Ki-67 nuclear staining of 10–15% of cells. Next Generation Sequencing of the tumor confirmed <i>ACTB::GLI1</i> fusion. In light of his neurodevelopmental disorders, further genetic evaluation was performed revealing <i>SHOX</i> deletion within PAR1 with complex Y-chromosomal rearrangement. Although <i>GLI1</i>-altered neoplasms have a distinctive morphology, lack of defining immunophenotype makes molecular confirmation of <i>GLI1</i>-altered soft tissue tumors essential in most cases. These tumors are low-grade sarcomas which are treated with complete local excision and long-term follow-up.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

GLI1-fusion neoplasm of the tongue: report of a pediatric case associated with SHOX deficiency disorder

  • 期刊论文

  • 发表日期：

    2026年5月20日

查看全文
  • Rana S. Alshagroud,
  • Reem M. Alrabiah,
  • Rasha S. AlRasheed,
  • Bader M. Aldawsari,
  • Ioannis G. Koutlas

摘要

GLI1-altered soft tissue tumor is a recently recognized entity featuring GLI1 fusions or amplifications, with predilection for the head and neck region and potential for metastasis. We report an additional case arising in the tongue of a 9-year-old boy with growth hormone insufficiency and epilepsy. Imaging showed an enhancing midline dorsal tongue lesion. Incisional biopsy revealed a multilobulated submucosal proliferation of monomorphic epithelioid-to-ovoid cells with prominent perivascular distribution around branching vessels and focal protrusion into vascular spaces. Tumor cells were GLUT-1 positive and negative for S100, GFAP, pan-cytokeratin, SMA, WT-1, CD31, CD34, STAT6, β-catenin, and HMB-45, with Ki-67 nuclear staining of 10–15% of cells. Next Generation Sequencing of the tumor confirmed ACTB::GLI1 fusion. In light of his neurodevelopmental disorders, further genetic evaluation was performed revealing SHOX deletion within PAR1 with complex Y-chromosomal rearrangement. Although GLI1-altered neoplasms have a distinctive morphology, lack of defining immunophenotype makes molecular confirmation of GLI1-altered soft tissue tumors essential in most cases. These tumors are low-grade sarcomas which are treated with complete local excision and long-term follow-up.